Performance · Recovery · Longevity

Shopping Cart (0)

Catalogue

Shop

Browse “Muscle/Performamnce, Recovery/Tissue, Weight Loss/Metabolic and Research Peptides“ and advanced wellness compounds. Prices are shown in South African Rand (ZAR).

Research peptides & wellness compounds

Select a product to view available quantities, specifications and regulatory status. Quantities, documentation and pricing are confirmed before dispatch.

GHK-Cu (UPA Platinum)

Category:
Recovery / Tissue
SKU:
TRW-GHKCU
Price:
R 550.00
{{variant.name}}:
{{opt.name}}
{{opt.value ? '' : opt.name}}
{{opt.value ? '' : opt.name}}
Description

TEST RUN WELLNESS GHK-Cu 100 | 100mg Copper Ion Peptide (Self-Mix Vial)

 

GHK-Cu 100mg – Copper-binding tripeptide with the most extensively documented gene-modulating profile in aesthetic peptide research. Rebuilds dermal collagen and elastin, breaks down scar-type collagen aggregates, restores skin firmness and elasticity, and supports hair follicle vitality and scalp health. Includes 2 ml bacteriostatic water.

 

Product Overview

GHK-Cu is a naturally occurring tripeptide — glycyl-L-histidyl-L-lysine — complexed with a copper ion. It is not a foreign or synthetic-only molecule: GHK is present in human plasma, saliva and urine, and the copper-bound form is the biologically active configuration. In plasma, GHK has an exceptionally high affinity for copper, and it circulates as a copper carrier, delivering the ion to cells and tissue where it is required for enzymatic and remodelling activity.

 

The peptide's defining property in the research literature is its breadth of gene modulation. GHK-Cu has been reported to reset the expression of a large set of human genes — on the order of several thousand — back toward a healthier, more youthful pattern, with the most consistent changes in genes governing collagen, elastin, glycosaminoglycans, antioxidant enzymes and inflammatory signalling. This is not a single-pathway compound; it is a remodelling signal.

 

Plasma GHK concentration falls with age, from approximately 200 ng/ml at age 20 to roughly 80 ng/ml by age 60, a decline that runs in parallel with reduced collagen density, slower wound closure and thinning skin and hair. That parallel is the core rationale behind GHK-Cu's use in skin, scalp and tissue-recovery protocols, and it is why the compound has held a central place in aesthetic research for decades.

 

GHK-Cu is supplied here as a 100 mg lyophilised powder in a self-mix vial with 2 ml bacteriostatic water. Reconstituting the full 2 ml yields 50 mg/ml, and a single vial carries enough material for an extended protocol at every dose tier. GHK-Cu is supplied at pharmaceutical grade for skin regeneration, collagen support and follicle health applications.

 

How GHK-Cu Works: Copper-Binding Gene Modulation Pathway

GHK-Cu's activity begins with copper delivery and ends with coordinated changes in the genes that build and maintain connective tissue.

 

At the first step, the tripeptide binds the copper(II) ion with high affinity and transports it into cells. Copper is an essential cofactor for lysyl oxidase — the enzyme that cross-links collagen and elastin into functional, load-bearing fibrils — and for superoxide dismutase, the primary intracellular antioxidant enzyme. Delivering copper in a peptide-bound, controlled form is central to GHK-Cu's mechanism, because free copper is both poorly utilised and pro-oxidant. Once inside the cell, the peptide-copper complex influences gene transcription.

 

The most consequential effect is a shift in collagen dynamics in two directions at once: upregulation of collagen types I, III and VI, elastin, decorin and glycosaminoglycan synthesis, and downregulation of the genes associated with scar-type collagen deposition. In practical terms, the remodelling signal instructs the body to break down extra-large, disorganised collagen aggregates characteristic of scar tissue and fibrotic skin, and to replace them with normal, organised, healthy collagen. That two-sided action — build the good, clear the bad — is what distinguishes GHK-Cu from simple collagen-stimulating actives.

 

Alongside this, GHK-Cu exerts potent antioxidant and anti-inflammatory activity. It suppresses the inflammatory cytokines and oxidative stress that degrade the dermal matrix — including the MMP enzymes that break down collagen under UV exposure and chronic inflammation — and supports healthy inflammatory resolution and tissue remodelling. It also stimulates angiogenesis and nerve outgrowth in healing tissue, improving the blood supply on which every remodelling process depends.

 

Applied to the scalp, the same mechanism set applies: improved follicular vascular supply, reduced perifollicular inflammation and a more supportive connective tissue environment around the follicle.

 

Body Recomposition Benefits

GHK-Cu's benefits are structural and aesthetic: it improves the quality, density and organisation of connective tissue rather than altering muscle mass, appetite or metabolic rate.

 

In research models, GHK-Cu has been used to study skin regeneration and collagen remodelling, and it is in that area that the compound's record is strongest. Reported outcomes include increased skin firmness and elasticity, visible reduction in fine lines and wrinkles, improved thickness and density of the dermal matrix, and accelerated wound healing with reduced scar formation.

 

Its antioxidant action protects the existing dermal matrix from the oxidative and UV-driven degradation that causes most visible skin ageing, which means the compound works on both sides of the equation — new tissue laid down and existing tissue preserved. Hair and follicle health is the second major application.

 

GHK-Cu has been reported to stimulate follicle vitality, improve scalp condition and support the appearance of thicker, stronger hair, with the mechanism attributed to improved follicular blood supply and a reduction in the inflammatory environment that contributes to follicle miniaturisation.

 

Systemic tissue recovery is the third. Because the copper-peptide complex drives remodelling rather than simply suppressing symptoms, it is used in recovery-oriented protocols to support healthy inflammatory responses, tissue remodelling and the gradual clearance of scar and fibrotic tissue — including in post-procedure aesthetic settings where controlled collagen remodelling is the goal.

 

It should be noted that the majority of robust, human-facing evidence for GHK-Cu concerns topical and cosmetic application, where measured outcomes such as skin firmness, wrinkle appearance and photodamage scores have been reported.

 

Systemic tissue-remodelling and follicle outcomes are supported primarily by mechanistic and preclinical work, and should be assessed as an active and well-documented research area rather than as settled human clinical fact.

 

Titration Protocol

GHK-Cu is administered via subcutaneous injection. The protocol is titrated by intended outcome rather than by body weight, and is built around a daily dose tier that escalates from aesthetic maintenance to deep recovery work.

A standard titration schedule is as follows:

· Aesthetic Support: 1 – 2 mg daily — skin health and anti-aging maintenance

 

· Tissue Recovery: 2 – 5 mg daily — deep recovery and repair

 

· Advanced Cycles: dose adjusted based on the individual regimen — consult a structured protocol

Volume figures assume reconstitution of the full 100 mg vial with the included 2 ml bacteriostatic water, giving 50 mg/ml.

 

At that concentration, 1 mg is 0.02 ml, 2 mg is 0.04 ml, and 5 mg is 0.10 ml. A single 100 mg vial therefore delivers 50–100 days at aesthetic doses or 20–50 days at recovery doses — one vial comfortably covers a full 8–12 week cycle at every tier without reordering.

 

Subcutaneous administration into abdominal or thigh fat is standard, and the extended cycle length means site rotation across abdomen, thigh and upper arm should be planned from the outset. For skin and scalp applications, a structured protocol may specify local administration technique; follow the protocol you are working to rather than improvising placement.

 

Reconstitute by directing the diluent down the inside wall of the vial and swirling gently — do not shake, to avoid denaturing the peptide. Use a new insulin or 0.5-inch needle per injection and disinfect the vial septum and injection site with an alcohol swab. Inject at a 45–90° angle into pinched subcutaneous tissue.

 

Because GHK-Cu is a copper complex, preparation hygiene matters more than with a plain peptide: keep the reconstituted solution clear of metal contact, do not reuse needles or syringes, and never draw with a needle that has already been used. Store the lyophilised vial refrigerated at 2–6 °C away from light, and store the reconstituted solution the same way, protected from light. Do not freeze after reconstitution.

 

Dose escalation should only proceed once the current tier is well tolerated. GHK-Cu is a slow-acting remodelling signal rather than an acute-response compound: the collagen turnover it supports operates on a timescale of weeks, so a full 8–12 week cycle at a given tier is the appropriate basis for judging response, not days. Keep the dose steady through a cycle rather than adjusting frequently, and complete the cycle before reassessing.

 

Combination Therapy

GHK-Cu is commonly used as part of broader aesthetic, skin-quality and recovery protocols:

 

· GHK-Cu + BPC-157: The most common aesthetic and tissue-repair pairing. GHK-Cu drives dermal collagen and elastin remodelling while BPC-157 addresses angiogenesis, inflammation and deeper soft-tissue repair.

 

The two are described as complementary — one rebuilding the connective tissue matrix, the other improving vascular supply and resolving inflammation in the tissue being remodelled.

 

· GHK-Cu + TB-500: Extends the pairing from dermal remodelling into broader soft-tissue recovery, with TB-500 contributing cell migration and actin-sequestration activity while GHK-Cu supplies the collagen and copper-dependent cross-linking signal.

 

· GHK-Cu + GH secretagogues (CJC-1295 with or without DAC, ipamorelin): Elevated pulsatile GH and IGF-1 raise systemic collagen synthesis and improve skin thickness, and GHK-Cu provides the localised remodelling and copper-delivery component. The combination is popular in aesthetic protocols targeting skin and hair quality alongside general recovery.

 

· GHK-Cu + matrix antioxidants (vitamin C, glutathione): Vitamin C is a required cofactor for collagen hydroxylation and works on the same end product as GHK-Cu through a different mechanism. Supporting antioxidant status protects the newly laid collagen from the oxidative degradation GHK-Cu is also working to reduce.

 

· GHK-Cu + post-procedure aesthetic care: Frequently used in structured recovery protocols for skin resurfacing, microneedling and similar procedures, where controlled collagen remodelling and scar-formation management are the treatment objectives.

 

All combination approaches should be pursued under professional medical supervision.

 

Clinical Trial Record

GHK-Cu has the longest research history of any copper peptide in aesthetic and wound-healing science, and that record is a genuine strength of the compound.

 

The foundational work on GHK established its natural presence in human plasma and its high-affinity copper binding, and identified its gene-modulating activity — the finding that the peptide shifts the expression of a broad set of human genes toward a regenerative, collagen-building pattern.

 

Subsequent research characterised the collagen and elastin upregulation, the downregulation of scar-type collagen deposition, the antioxidant and anti-inflammatory effects, and the angiogenic and nerve-outgrowth activity that underpin its use in skin and tissue recovery.

 

In human application, GHK-Cu is one of the few peptides with a documented record of measured aesthetic outcomes. Formulated and applied topically, it has been reported in clinical and cosmetic studies to improve skin firmness and elasticity, reduce the appearance of fine lines and wrinkles, and improve the appearance of photodamaged skin, with reported increases in collagen density in treated skin.

 

Cosmetic formulations have historically used concentrations in the region of 1–2% of the copper peptide. The compound has an established record of use in wound-healing and post-procedure skin recovery research, where accelerated healing and improved scar appearance have been reported.

 

Its safety profile in topical cosmetic use is well described, with generally good tolerability and a low rate of reported irritation. This tolerability, combined with the breadth of its documented mechanism, is why GHK-Cu has remained a reference compound in copper-peptide research and in professional aesthetic practice.

 

Technical Specifications

· Product Name: GHK-Cu 100
· Peptide: GHK-Cu (glycyl-L-histidyl-L-lysine copper complex; copper ion peptide)
· Concentration: 100mg per vial
· Form: Self-mix vial — lyophilised powder
· Reconstitution: Requires bacteriostatic water for reconstitution (2ml included)
· Reconstituted concentration: 50 mg/ml (100mg in 2ml)
· Purity: Pharmaceutical grade
· Administration: Subcutaneous injection, once daily
· Cycle length: 8–12 weeks per tier, with a break before repeat cycling
· Presentation: Single 100mg vial with diluent — supports 20–100 days of protocol depending on dose tier
· Storage: Refrigerated at 2–6 °C, away from light; do not freeze after reconstitution

· Supplier: Test Run Wellness (Wellness.testrun)

 

⚕️ Important Medical Notice

Please consult your medical practitioner regarding your body requirements, as the dosing information provided contains guideline dosages. GHK-Cu is intended for use under professional medical supervision.

 

Do not use in pregnancy or breastfeeding, or in anyone under 18 years of age. Do not use with active malignancy or a history of malignancy. Use with caution — and only under clinician supervision — in patients with cardiovascular disease, active bleeding, coagulopathy, or those on anticoagulant or antiplatelet therapy. Copper metabolism disorders, including Wilson's disease and other conditions of impaired copper handling, are a contraindication. Avoid use at a site of active infection, recent surgery or acute inflammation. No interaction data exist with NSAIDs, corticosteroids, immunosuppressants or any other medicine.

 

Regulatory notice. Test Run Wellness is an independent supplier and is not the manufacturer of the products referenced. No product should be used without appropriate regulatory authorisation and professional medical oversight.